GLP-1 Medicines for Weight Loss: What Patients Should Know
GLP-1–based medicines can be an important part of Weight Loss treatment for selected patients. They can reduce appetite and increase feelings of fullness, while some also improve blood glucose control.
How they work
GLP-1 receptor agonists mimic the action of glucagon-like peptide-1. Tirzepatide acts on both GIP and GLP-1 pathways.
Who may benefit?
Weight-management medicines may be considered when lifestyle measures alone are not enough and a person meets the medical criteria for treatment. The exact indication depends on the medicine, formulation and country.
Medication plus lifestyle
These medicines work best as part of a comprehensive plan that includes appropriate nutrition, physical activity, sleep and regular medical follow-up.
Semaglutide and tirzepatide
Semaglutide is a GLP-1 receptor agonist, while tirzepatide activates both GIP and GLP-1 receptors. Different products and doses have different approved uses, so they should not be treated as interchangeable.
Medical supervision matters
Follow-up may include Weight Loss progress, blood glucose when relevant, gastrointestinal symptoms, hydration, nutritional intake and other medical conditions. Medication choice and dosing should be individualized by a qualified healthcare professional.
Medical note: This article is for general education and does not replace an individual medical consultation.
